β¨ Health Notices
NEW ZEALAND GAZETTE
No. 11
Health
Medicines Act 1981
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Mesalazine 16.67% (500 mg) | Suppository, rectal | Montefarmaco SpA., Pero (Milano), Italy | Asacol |
| Benzoyl peroxide 50 mg/mL in 200 mL | Solution, topical | Galderma Laboratories, de Montdesir, Alby Sur Cheran, France | Benzac AC Wash 5% |
| Pyrantel embonate equivalent to 100 mg pyrantel base per square | Chocolate, medicated | Mentholatum Australasia Pty Limited, Scoresby, Victoria, Australia | Combantrin Chocolate Squares |
Dated this 30th day of January 1997.
KAREN O. POUTASI (Dr), Director-General of Health, pursuant to delegation given by the Minister of Health on 18 January 1996.
go770
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Sodium acid phosphate 1 mmol/mL in 20 mL | Injection, ampoule | McGaw Biomed Limited, Point Chevalier, Auckland | |
| Methadone hydrochloride 10 mg/mL in 100 mL, 200 mL, 500 mL | Solution, oral | McGaw Biomed Limited, Point Chevalier, Auckland | Biodone Extra Forte |
| Methadone hydrochloride 5 mg/mL in 100 mL, 200 mL, 500 mL | Solution, oral | McGaw Biomed Limited, Point Chevalier, Auckland | Biodone Forte |
| Adrenaline 1 mg/mL in 0.3 mL | Injection, prefilled syringe | Meridian Medical Technologies Inc., St. Louis, Missouri, United States of America | EpiPen Auto Injector |
| Adrenaline 0.5 mg/mL in 0.3 mL | Injection, prefilled syringe | Meridian Medical Technologies Inc., St. Louis, Missouri, United States of America | EpiPen Jr Auto Injector |
| Cajuput oil 0.5%, camphor 3.5%, capsicum 0.15%, eucalyptus oil 3.0%, menthol 5.0%, methyl salicylate 20.0%, peppermint oil 0.5%, pine oil 1.0%, turpentine 1.0% | Cream, skin | Herron Pharmaceuticals Pty Limited, Tennyson, Queensland, Australia | Goanna Heat Cream |
| Benzalkonium chloride 0.1% w/w, tolnaftate 1.0% w/w | Cream | The Boots Company plc., Nottingham, United Kingdom | Mycota |
| Chlorhexidine hydrochloride 0.25 w/w, tolnaftate 1.0% w/w | Powder | The Boots Company plc., Nottingham, United Kingdom | Mycota |
| Chlorpheniramine maleate 1 mg, dextromethorphan hydrobromide 7.5 mg per 5 mL in 100 mL | Syrup | Sigma Pharmaceuticals Pty Limited, Clayton, Victoria, Australia | Orthoxicol for Children Nightrest Cough Mixture |
| Azelastine hydrochloride 0.1% w/v in 10 mL | Spray, nasal metered | Asta Medica AG., Frankfurt, Germany | Rhinolast |
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1997, No 11
NZLII —
NZ Gazette 1997, No 11
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social Welfare30 January 1997
Medicines Act 1981, Changed Medicines, Consent, Distribution, Mesalazine, Benzoyl Peroxide, Pyrantel Embonate
- KAREN O. POUTASI (Dr), Director-General of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare30 January 1997
Medicines Act 1981, New Medicines, Consent, Distribution, Sodium Acid Phosphate, Methadone Hydrochloride, Adrenaline, Cajuput Oil, Benzalkonium Chloride, Chlorhexidine Hydrochloride, Chlorpheniramine Maleate, Azelastine Hydrochloride
- KAREN O. POUTASI (Dr), Director-General of Health